Brian Elsbernd - 08 Sep 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Signature
/s/ Brian Elsbernd
Issuer symbol
CPRX
Transactions as of
08 Sep 2025
Transactions value $
-$357,056
Form type
4
Filing time
10 Sep 2025, 17:00:26 UTC
Previous filing
05 Sep 2025
Next filing
14 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Elsbernd Brian Chief Compliance/Legal Officer 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ Brian Elsbernd 10 Sep 2025 0001763511

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Options Exercise $252K +112K +59.65% $2.24 301K 08 Sep 2025 Direct
transaction CPRX Common Stock, par value $0.001 per share Sale -$609K -30K -9.97% $20.30 271K 08 Sep 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to Purchase Common Stock Options Exercise $0 -112K -11.73% $0.00 847K 08 Sep 2025 Common Stock 112K $2.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported as sold herein and in Table I to the Reporting Person's Form 4 filed with the SEC on September 5, 2025 were sold on the open market to fund the exercise price and tax withholding due from Mr. Elsbernd on the exercise of the 112,475 stock options reported in Table II hereto and the 50,000 stock options reported on Table II to the Reporting Person's Form 8-K filed with the SEC on September 5, 2025.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range from $20.225 to $20.315 per share.
F3 Options vested in three annual tranches beginning on December 19, 2019.